Goddard AF, James MW, McIntyre AS, et al. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309-1316.
US Preventive Services Task Force. Screening for iron deficiency anemia: including iron supplementation for children and pregnant women. May 2006. http://www.uspreventiveservicestaskforce.org (last accessed 21 February 2017).
Pavord S, Myers B, Robinson S, et al; British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156:588-600.
Gera T, Sachdev HS, Boy E. Effect of iron-fortified foods on hematologic and biological outcomes: systematic review of randomized controlled trials. Am J Clin Nutr. 2012;96:309-324.
Mitra AK, Khoury AJ. Universal iron supplementation: a simple and effective strategy to reduce anaemia among low-income, postpartum women. Public Health Nutr. 2012;15:546-553.
WHO, UNICEF, UNU. Iron deficiency anaemia: assessment, prevention, and control. WHO/NHD/01.3. Geneva, Switzerland: World Health Organization; 2001.
US Preventative Services Task Force. Iron deficiency anemia in pregnant women: screening and supplementation. September 2015. http://www.uspreventiveservicestaskforce.org (last accessed 21 February 2017).
US Preventative Services Task Force. Iron deficiency anemia in young children: screening. September 2015. http://www.uspreventiveservicestaskforce.org (last accessed 21 February 2017).
Cantor AG, Bougatsos C, Dana T, et al. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2015;162:566-576.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol. 2008;112:201-207.
Pritchard JA. Hemoglobin regeneration in severe iron-deficiency anemia. Response to orally and parenterally administered iron preparations. JAMA. 1966;195:717-720.
Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007;369:1502-1504.
1. Goddard AF, James MW, McIntyre AS, et al. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309-1316.
2. Ruston D, Hoare J, Henderson L, et al. The National Diet and Nutrition Survey: adults aged 19-64 years. Volume 4: Nutritional status (anthropometry and blood analytes), blood pressure and physical activity. The Stationery Office. London. 2004.
3. Hallberg, L, Hulten, L, Lindstedt G, et al. Prevalence of iron deficiency in Swedish adolescents. Pediatr Res. 1993;34:680-687.
4. Centers for Disease Control and Prevention. Iron deficiency: United States, 1999-2000. MMWR. Morb Mortal Wkly Rep. 2002; 51: 897-899.
5. Zlotkin SH, Ste-Marie M, Kipelman H, et al. The prevalence of iron depletion and iron-deficiency anaemia in a randomly selected group of infants from four Canadian cities. Nutr Res. 1996;16:729.
6. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998;47:1-36.
7. Beutler E. Disorders of iron metabolism. In: Lichtman MA, Beutler E, Kipps TJ, et al. Williams hematology. 7th ed. New York: McGraw-Hill Medical; 2006: 511-559,803-822.
8. Ramakrishnan U, Frith-Terhune A, Cogswell M, et al. Dietary intake does not account for differences in low iron stores among Mexican American and non-Hispanic white women: Third National Health and Nutrition Examination Survey, 1988-1994. J Nutr. 2002;132:996-1001.
9. Comite Nacional de Hematologia. [Iron deficiency anemia. Guideline for diagnosis and treatment [in Spanish]. Arch Argentin Pediatr. 2009;107:353-361.
10. Karl JP, Lieberman HR, Cable SJ, et al. Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation. Am J Clin Nutr. 2010;92:93-100.
11. Osei AK, Rosenberg IH, Houser RF, et al. Community-level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. J Nutr. 2010;140:1146-1154.
12. Rivera JA, Shamah T, Villalpando S, et al. Effectiveness of a large-scale iron-fortified milk distribution program on anemia and iron deficiency in low-income young children in Mexico. Am J Clin Nutr. 2010;91:431-439.
13. McClung JP, Karl JP, Cable SJ, et al. Randomized, double-blind, placebo-controlled trial of iron supplementation in female soldiers during military training: effects on iron status, physical performance, and mood. Am J Clin Nutr. 2009;90:124-131.
14. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75:671-678.
15. Andrews, NC. Iron deficiency and related disorders. In: Lee GR, Foerster J, Lukens J, et al., eds. Wintrobe's clinical hematology. Baltimore, MD: Lippincott, Williams & Wilkins; 1999:979-1010.
16. Pasricha SR, Drakesmith H, Black J, et al. Control of iron deficiency anemia in low- and middle-income countries. Blood. 2013;121:2607-2617.
17. Johnson-Spear MA, Yip R. Hemoglobin difference between black and white women with comparable iron status: justification for race-specific anemia criteria. Am J Clin Nutr. 1994;60:117-121.
18. Waldmann A, Koschizke JW, Leitzmann C, et al. German vegan study: diet, life-style factors, and cardiovascular risk profile. Ann Nutr Metab. 2005;49:366-372.
19. Harvey LJ, Armah CN, Dainty JR, et al. Impact of menstrual blood loss and diet on iron deficiency among women in the UK. Br J Nutr. 2005;94:557-564.
20. Aikawa R, Khan NC, Sasaki S, et al. Risk factors for iron-deficiency anaemia among pregnant women living in rural Vietnam. Public Health Nutr. 2006;9:443-448.
21. Roger S. The CARI guidelines. Haematological targets. Iron. Nephrology (Carlton). 2006;11(suppl 1):S217-S229.
22. Schiesser D, Binet I, Tsinalis D, et al. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. Nephrol Dial Transplant. 2007;21:2841-2845.
23. Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease. Blood. 2007;109:412-421.
24. Tovey FI, Hobsley M. Post-gastrectomy patients need to be followed up for 20-30 years. World J Gastroenterol. 2000;6:45-48.
25. Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327:749-754.
26. Bodnar LM, Cogswell ME, Scanlon KS. Low income postpartum women are at risk of iron deficiency. J Nutr. 2002;132:2298-302.
27. Nead KG, Halterman JS, Kaczorowski JM, et al. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004;114:104-108.
28. DuBois S, Kearney DJ. Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol. 2005;2004;100:453-459.
29. Baggett HC, Parkinson AJ, Muth PT, et al. Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics. 2006;117:396-404.
30. Qu XH, Huang XL, Xiong P, et al. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol. 2010;16:886-896.
31. Cardenas VM, Mulla ZD, Ortiz M, et al. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006;163:127-134.
32. Huang X, Qu X, Yan W, et al. Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J. 2010;86:272-278.
33. Yuan W, Li Y, Yang K, et al. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2010;45:665-676.
34. US Preventive Services Task Force. Screening for iron deficiency anemia: including iron supplementation for children and pregnant women. May 2006. http://www.uspreventiveservicestaskforce.org (last accessed 21 February 2017).
35. Pavord S, Myers B, Robinson S, et al; British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156:588-600.
36. Gera T, Sachdev HS, Boy E. Effect of iron-fortified foods on hematologic and biological outcomes: systematic review of randomized controlled trials. Am J Clin Nutr. 2012;96:309-324.
37. Imdad A, Bhutta ZA. Routine iron/folate supplementation during pregnancy: effect on maternal anaemia and birth outcomes. Paediatr Perinat Epidemiol. 2012;26(suppl 1):168-177.
38. Peña-Rosas JP, De-Regil LM, Malave HG, et al. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(10):CD009997.
39. Nogueira Arcanjo FP, Santos PR, Arcanjo CP, et al. Use of iron-fortified rice reduces anemia in infants. J Trop Pediatr. 2012;58:475-480.
40. Mitra AK, Khoury AJ. Universal iron supplementation: a simple and effective strategy to reduce anaemia among low-income, postpartum women. Public Health Nutr. 2012;15:546-553.
41. Haider BA, Olofin I, Wang M, et al; Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013;346:f3443.
42. Neuberger A, Okebe J, Yahav D, et al. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev. 2016;(2):CD006589.
43. World Health Organization. Daily iron supplementation in infants and children. 2016. http://www.who.int/nutrition/ (last accessed 21 February 2017).
44. World Health Organization. Daily iron supplementation in adult women and adolescent girls. 2016. http://www.who.int/nutrition/ (last accessed 21 February 2017).
45. Low M, Farrell A, Biggs BA, et al. Effects of daily iron supplementation in primary-school-aged children: systematic review and meta-analysis of randomized controlled trials. CMAJ. 2013;185:E791-E802.
46. Taylor TA, Kennedy KA. Randomized trial of iron supplementation versus routine iron intake in VLBW infants. Pediatrics. 2013;131:e433-e438.
47. Wang B, Zhan S, Gong T, et al. Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database Syst Rev. 2013;(6):CD001444.
48. WHO, UNICEF, UNU. Iron deficiency anaemia: assessment, prevention, and control. WHO/NHD/01.3. Geneva, Switzerland: World Health Organization; 2001.
49. Thomas DW, Hinchliffe RF, Briggs C, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013;161:639-648.
50. Means RT Jr. Hepcidin and anaemia. Blood Rev. 2004;18:219-225.
51. Beutler E, Hoffbrand A, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program. 2003;40-61.
52. Gamaldo CE, Earley CJ. Restless legs syndrome: a clinical update. Chest. 2006;130:1596-1604.
53. McCann JC, Ames BN. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr. 2007;85:931-945.
54. Falkingham M, Abdelhamid A, Curtis P, et al. The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J. 2010;9:4.
55. Hegde N, Rich MW, Gayomali C. The cardiomyopathy of iron deficiency. Tex Heart Inst J. 2006;33:340-344.
56. The relation of iron to blood platelets. Nutr Rev. 1976;34:25-27.
57. Ioannou GN, Spector J, Scott K, et al. Prospective evaluation of a clinical guideline for the diagnosis and management of IDA. Am J Med. 2002;113:281-287.
58. Bovy C, Gothot A, Delanaye P, et al. Mature erythrocyte parameters as new markers of functional iron deficiency in hemodialysis: sensitivity and specificity. Nephrol Dial Transplant. 2007;22:1156-1162.
59. Hershko C, Camaschella C. How I treat unexplained refractory iron deficiency anemia. Blood. 2014;123:326-333.
60. Peytremann-Bridevaux I, Arditi C, Froehlich F, et al; EPAGE II Study Group. Appropriateness of colonoscopy in Europe (EPAGE II). Iron-deficiency anemia and hematochezia. Endoscopy. 2009;41:227-233.
61. Koulaouzidis A, Said E, Cottier R, et al. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis. 2009;18:345-352.
62. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997 Feb 1;89(3):1052-7.
63. Labbe RF, Vreman HJ, Stevenson DK. Zinc protoporphyrin: a metabolite with a mission. Clin Chem. 1999;45:2060-2072.
64. Nittis T, Gitlin JD. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol. 2002;39:282-289.
65. US Preventative Services Task Force. Iron deficiency anemia in pregnant women: screening and supplementation. September 2015. http://www.uspreventiveservicestaskforce.org (last accessed 21 February 2017).
66. US Preventative Services Task Force. Iron deficiency anemia in young children: screening. September 2015. http://www.uspreventiveservicestaskforce.org (last accessed 21 February 2017).
67. Cantor AG, Bougatsos C, Dana T, et al. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2015;162:566-576.
68. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol. 2008;112:201-207.
69. American Academy of Family Physicians. Summary of recommendations for clinical preventive services. January 2016. http://www.aafp.org (last accessed 21 February 2017).
70. Pritchard JA. Hemoglobin regeneration in severe iron-deficiency anemia. Response to orally and parenterally administered iron preparations. JAMA. 1966;195:717-720.
71. Liu TC, Lin SF, Chang CS, et al. Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of IDA: a Taiwanese study. Int J Hematol. 2004;80:416-420.
72. Aapro M, Österborg A, Gascón P, et al. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol. 2012;23:1954-1962.
73. Gascón, P. Iron therapy in cancer-induced anemia. Transfus Altern Transfus Med. 2012;12:130-134.
74. Lee TW, Kolber MR, Fedorak RN, et al. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6:267-275.
75. Reinisch W, Staun M, Tandon RK, et al. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108:1877-1888.
76. Comin-Colet J, Lainscak M, Dickstein K, et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J. 2013;34:30-38.
77. Kansagara D, Dyer E, Englander H, et al. Treatment of anemia in patients with heart disease: a systematic review. Ann Intern Med. 2013;159:746-757.
78. Beck-da-Silva L, Piardi D, Soder S, et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol. 2013;168:3439-3442.
79. Pieracci FM, Stovall RT, Jaouen B, et al. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness. Crit Care Med. 2014;42:2048-2057.
80. Ng O, Keeler BD, Mishra A, et al. Iron therapy for pre-operative anaemia. Cochrane Database Syst Rev. 2015;(12):CD011588.
81. Froessler B, Palm P, Weber I, et al. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016;264:41-46.
82. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res. 2013;39:504-510.
83. Perelló MF, Coloma JL, Masoller N, et al. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. BJOG. 2014;121:706-713.
84. Avni T, Bieber A, Grossman A, et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90:12-23.
85. Macdougall IC, Strauss WE, McLaughlin J, et al. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. Clin J Am Soc Nephrol. 2014;9:705-712.
86. Hetzel D, Strauss W, Bernard K, et al. A phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. Am J Hematol. 2014;89:646-650.
87. Onken JE, Bregman DB, Harrington RA, et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion. 2014;54:306-315.
88. Khalafallah A, Dennis A, Bates J, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med. 2010;268:286-295.
89. Bailie GR, Mason NA, Valaoras TG. Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Hemodial Int. 2010;14:47-54.
90. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436-2448.
91. Van Wyck DB, Mangione A, Morrison J, et al. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. 2009;49:2719-2728.
92. Wang C, Graham DJ, Kane RC, et al. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA. 2015;314:2062-2068.
93. Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail. 2012;14:423-429.
94. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007;369:1502-1504.
95. Auerbach M, Chaudhry M, Goldman H. Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial. J Lab Clin Med. 1998;257-260.
96. Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis. 1999;33:464-470.
97. Sav T, Tokgoz B, Sipahioglu MH, et al. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail. 2007;29:423-426.
98. Singh A, Patel T, Hertel J, et al. Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis. 2008;52:907-915.
99. Ahmad I, Gibson PR. Management of iron deficiency in patients admitted to hospital: time for a rethink of treatment principles. Intern Med J. 2006; 36:347-354.
100. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev. 2006;20:273-282.
101. Thompson J, Biggs BA, Pasricha SR. Effects of daily iron supplementation in 2- to 5-year-old children: systematic review and meta-analysis. Pediatrics. 2013;131:739-753.
102. Chan KK, Chan BC, Lam KF, et al. Iron supplement in pregnancy and development of gestational diabetes: a randomised placebo-controlled trial. BJOG. 2009;116:789-798.
103. Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol. 2007;44:32-41.
104. Engle PL, Black MM, Behrman JR, et al. Strategies to avoid the loss of developmental potential in more than 200 million children in the developing world. Lancet. 2007;369:229-242.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台